Decentralized Trials That Scale Globally Without Compliance Risks - with Emma Vitalini of Amgen

Decentralized Trials That Scale Globally Without Compliance Risks - with Emma Vitalini of Amgen

0 Anmeldelser
0
Episode
1120 of 1113
Længde
30M
Sprog
Engelsk
Format
Kategori
Økonomi & Business

Today's guest is Emma Vitalini, Head of Global Digital Health Technology Innovation at Amgen. Amgen is a global biotechnology company focused on discovering, developing, and delivering medicines for serious illnesses. Emma joins Emerj Editorial Director Matthew DeMello to examine how data and AI are reshaping patient recruitment, decentralized clinical trials, and compliance workflows in highly regulated healthcare environments. Emma also discusses practical ways AI can surface unstructured genomic and clinical data to improve patient identification, how API-based access supports hypothesis testing without large-scale data movement, and how modular consent and explainable AI frameworks help sponsors scale trial operations while maintaining regulatory trust and patient transparency. Learn how brands work with Emerj and other Emerj Media options at go.emerj.com/partner


Lyt når som helst, hvor som helst

Nyd den ubegrænsede adgang til tusindvis af spændende e- og lydbøger - helt gratis

  • Lyt og læs så meget du har lyst til
  • Opdag et kæmpe bibliotek fyldt med fortællinger
  • Eksklusive titler + Mofibo Originals
  • Opsig når som helst
Prøv nu
DK - Details page - Device banner - 894x1036
Cover for Decentralized Trials That Scale Globally Without Compliance Risks - with Emma Vitalini of Amgen

Other podcasts you might like ...